Guido D.

Quality executive with 24+ years experience in Biotech & Pharmaceuticals

English, German, Spanish; Castilian, French

Research, Development, Production and Quality of Vaccines and Biopharmaceuticals (Biosimilars).

  • Biotech, Pharma & Life Sciences
  • Biotech, Pharma & Life Sciences
  • Quality


  • Pre-vetted expert
  • Confirmed hourly rate
  • Available on short notice


Vice President Quality Biologics and Steriles

6 years
Current position
Sep 2016 - Present
Merck KGaA, operating in Canada and the United States as EMD, is a German chemical and pharmaceutical company headquartered in Darmstadt.

Vice President, Global Head of Quality

2 years
Mar 2014 - Aug 2016
Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and food sectors, headquartered in Basel, with major facilities in Europe, North America...see more

Head Global QA Biopharmaceuticals

Novartis - Sandoz
2 years
Sep 2011 - Mar 2014
Head of Quality for Development and Commercial Manufacturing of Biosimilars

Vice President Global Quality Assurance

GlaxoSmithKline Biologicals
2 years
Jan 2010 - Sep 2011
Global VP Quality Assurance for all Vaccine Manufacturing Sites of GSK Biologicals (located in North America, Europe and Asia)

Director of Bulk Technologies

GlaxoSmithKline Biologicals
3 years
Jan 2007 - Jan 2010
Investment Projects in Vaccine Manufacturing Facilities in North America, Europe and Asia

VP Operations

Berna Biotech / Crucell
6 years
Jan 2001 - Jan 2007
Research and Development of Vaccines, Manufacturing of Vaccines, Site Director of US-FDA approved Vaccine Manufacturing Site

Research Group Leader

Julius-Maximilians-Universität Würzburg, Institute for Hygiene and Microbiology
1 year
Jan 2000 - Jan 2001
Research on Vaccines against Meningococcal Meningitis


Boehringer Ingelheim
1 year
Jan 1999 - Jan 2000
Research in the areas of Genomics/Transciptomics (with DNA mciroarrays and DNA chips) and Research in the area of Diabetes/Metabolic Disorders


Chiron Behring
1 year
Jan 1998 - Jan 1999
Research on Vaccines against Tuberculosis using DNA Microarrays. Improvement of Production Method for licenced Vaccine against Tuberculosis (BCG Vaccine).

Industries, roles and expertise

Industry experience

  • Biotech, Pharma & Life Sciences
  • Biotech, Pharma & Life Sciences

Role experience

  • Quality